15th Legal Affairs Conference
Section
Public Affairs
Event Location
Netherlands
Event Description
The 2019 Medicines for Europe Legal Affairs Conference will take place, for the first time, in Amsterdam.
In its 15th edition, this conference will provide participants with the opportunity to exchange views and share ideas with leading industry executives and experts, counsel and European institution officials around the latest developments in intellectual property and legal affairs concerning generic, biosimilar and value added medicines within Europe and worldwide.
The conference will address:
– A General Counsel discussion on international developments around IP and competition
– What to expect from the pharma incentives review and from the Supplementary Protection Certificate (SPC) Regulation
– The SPC Manufacturing Waiver: what conclusions can be drawn?
– Brexit: the IP landscape and business strategies for the sector
– What’s new on Biosimilars: opportunities or challenges for biosimilar medicine developers?
– The latest developments at the European Patent Office
Attend the event and join in shaping discussions at the interactive roundtables on topics that will include GDPR, data confidentiality, second medical use patents, the falsified medicines directive, the 505(b)(2) system in the US, international developments at WIPO, and more…
Events of the week
Jobs
Fourtold
The U.S. Mission to the EU
Wilfried Martens Centre for European Studies
European Federation of Public Service Unions (EPSU)
European Network of Cultural Centres
Acumen Public Affairs
Centre on Regulation in Europe (CERRE)
Network to Promote Linguistic Diversity
EURACTIV News
- Commission pushing fertiliser sector too hard, too fast, says Achema CEO [Advocacy Lab Content]
- Europe’s green future needs more private investment, urgently
- Bulgaria reports 27% increase in antibiotic use, leading to fears of rising AMR deaths
- Belgian MEP calls for an EU women’s health strategy, says EU pharma reform can go further
- Nuclear tender in Czechia: anti-monopoly office preliminarily rejects EDF and Westinghouse complaints